Clinical Trial Update: Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and tolerability of inhaled nitric oxide in subjects with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Beyond Air Inc. | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED